skip to Main Content
NEWS
[Global Economic] C&R Research And GC Cell Signed An MOU To ‘Strengthen Global Clinical Competitiveness’

[Global Economic] C&R Research and GC Cell signed an MOU to ‘Strengthen Global Clinical Competitiveness’

C&R Research and GC Cell signed an MOU to strengthen global clinical competitiveness and sales power.   Through this business…

Read more →
[Hitnews] C&R Research, Conducting A Phase 1 Clinical Trial For ‘Non-Small Cell Lung Cancer’ Of ONCOBIX

[Hitnews] C&R Research, conducting a Phase 1 clinical trial for ‘Non-Small Cell Lung Cancer’ of ONCOBIX

C&R Research (CEO Moon-Tae Yoon) announced about conducting a Phase 1 clinical trial for 'Non-Small Cell Lung Cancer' of ONCOBIX…

Read more →
[Edaily] C&R Research Led US FDA Approval Of ‘EYELEA’ Phase 3 IND Clinical Trial

[Edaily] C&R Research led US FDA approval of ‘EYELEA’ Phase 3 IND clinical trial

C&R Research successfully carried out US FDA approval for the Phase 3 IND clinical trial of 'EYELEA' Biosimilar with Rophibio,…

Read more →
[Yakup] C&R Research, Successfully Completed US FDA Medical Device 510(k) Approval Work

[Yakup] C&R Research, Successfully completed US FDA medical device 510(k) approval work

C&R Research (CEO Moon-Tae Yoon) successfully carried out the US FDA medical device 510(k) approval work, expanding business scope to…

Read more →
[Edaily] Moon-Tae Yoon, CEO Of C&R Research, Collaborates With Kakao On CDISC Clinical Standardization… ‘Crossing The FDA Threshold’

[Edaily] Moon-Tae Yoon, CEO of C&R Research, collaborates with Kakao on CDISC clinical standardization… ‘Crossing the FDA Threshold’

C&R Research, a contract research organization (CRO) is undergoing a complete overhaul of its clinical data collection method. They are…

Read more →
Back To Top